no results
Ihre Produkte genau hier!
Ihre Suche lieferte keine Ergebnisse, aber Sie können sich mit Ihren Produkten und Leistungen auf dieser Seite präsentieren
Mit einem Eintrag auf Weltzentrum der Medizintechnik platzieren Sie Ihre Produkte und Dienstleistungen bei Google & Co. ganz weit oben und erreichen so jeden Tag mehrere Tausend potentielle Kunden aus der Medizintechnikbranche. Mehr Informationen gibt es auf der Firma eintragen - Seite.
no results
Ihr Unternehmen genau hier!
Ihre Suche lieferte keine Ergebnisse, aber Sie können sich auf dieser Seite präsentieren
Mit einem Eintrag auf Weltzentrum der Medizintechnik platzieren Sie Ihr Unternehmen bei Google & Co. ganz weit oben und erreichen so jeden Tag mehrere Tausend potentielle Kunden aus der Medizintechnikbranche. Mehr Informationen gibt es auf der Firma eintragen - Seite.
Vessel closure device
A power driven vessel closure device is a medical device that closes a hole in the wall of a body lumen. The system includes a handle, power operated drive system, and one or more sheaths with a proximal end that is coupled to the handle. The device has an elongated drive member and a closure element that is retracted within the sheath when not in use.
The device is typically used to close a large-bore arteriotomy. There are many types of closure devices, including suture-based and balloon-based devices. Perclose is the most common and is available in both manual and electronic versions. It has received CE Mark approval and is manufactured by Essential Medical, Inc. It has been tested and approved in several first-in-man studies. X-Seal VCD has a proven clinical and angiographic performance.
The Mynx Vascular Closure Device is another passive extravascular closure device. This device utilizes a polyglycolic acid plug that dissolves within 60 to 90 days. It is delivered through a procedural sheath and is indicated for closing 8.5 to 10-F arteriotomies. This device is indicated for small-to-medium-sized arteriotomies. It is not indicated for use in arteries with larger diameters than 5 mm.
In addition to a Vessel Closure Device, there are other options that are becoming available. Some of these include the Mynx Vascular Closure Device (MMC), which uses a bioresorbable silicone polymer implant to seal access sites. This device does not have an intraarterial component, but it is an alternative to manual compression. This device can be more effective for older patients with blood clotting disorders, patients who are obese, and patients with large arterial access.
The ProStar device is used to close arterial CPBs. Its effectiveness is 96.4%. The ProStar is used for MIS MV surgery. It is safe for most patients, and requires minimal surgical intervention. The success rate is 97% in the first 50 patients and 98.2% after the first 50 patients. The ProStar device also has similar success rates. It is a reliable and effective option for MIS MV procedures.
However, VCDs have many potential risks. Some are potentially life-threatening. A stent, for example, may lead to ischemia in the leg. The device can cause a thrombotic complication. A valve, on the other hand, could cause an arterio-venous fistula. A VCD can also cause complications such as bleeding and nerve damage. These risks are the main reasons for not using a device.
While many advantages of a Vessel Closure Device include its ability to prevent rebleeding, it also has potential disadvantages. The Axera device uses a shape memory clip to prevent premature clip deployment. It can be inserted into the patient's vessel after sheath removal. It can even be used in diagnostic procedures. A Vessel Closure Device should only be used after careful evaluation by a physician. This is the best option if you are not a surgeon.
The Mynx Vascular Closure Device is a nitinol clip that deploys outside an artery to occlude the site of an arteriotomy. It is inserted through a procedural sheath. A small, semicompliant balloon anchors it in place. The sealant is then deployed outside the artery wall. The device then expands to achieve hemostasis. The balloon is then removed through the trachea.
The Mynx Vascular Closure Device, manufactured by AccessClosure, features a polyethylene glycol sealant that deploys outside the artery, occlusing the arteriotomy site. The Mynx is a polyethylene glycol device that is implanted through an existing procedural sheath. Its small, semicompliant balloon is inflated within the artery, anchors the sealant, and is removed through the tract.
The Manta device, which uses an intraluminal anchor and collagen implant, is currently in early development and has completed a pivotal IDE trial. The company expects to file its premarket application with the FDA in the first quarter of 2018. It has also demonstrated that it can seal high-pressure vessels in less than 60 seconds, despite its complexity. Its safety has been affirmed by a number of studies.